Expression of Micro-RNA 218 in Cervical Cancer and Its Effect on Proliferation, Apoptosis and Invasion of HeLa Cells

SHI Yu-rong, LIU Jian, HE Wei. et al

Abstract

To investigate the expression and clinical significance of microRNA-218 (miR-218) in human cervical cancer and the effects ofmiR-218 on proliferation, cell apoptosis and invasion of HeLa cells. Methods QRT-PCR was used to detect the expression ofmiR-218 in 23 cases of normal cervical tissues and 114 cases of cervical cancer, and the relationship between the expression and the clinicopathological features was analyzed; HeLa cells were devided into three groups: non transfection (control group), transfected with empty liposomes negative control goup (NC group), transfected with miR-218 mimic (miR-218M group). The cell growth inhibiting ratio of HeLa cells was assessed by MTT assay. Fluorescence activated cell sorting was used to measure cell apoptosis. Changes of cell migration ability were detected by wound healing test and Transwell assay. QRT-PCR and Western blot were used to detect the expression of Bcl-2, Bax, NF-κB and E-cadherin, respectively. Results The expression ofmiR-218 in cervical cancer was down regulated, and there were significant differences in the different pathological types, stages, lymph node metastasis and interstitial infiltration in cervical cancer tissues (P Bcl-2 mRNA and protein were down-regulated and Bax mRNA and protein expression levels were increased, E-cadherin mRNA and protein expression were up-regulated, but NF -κB mRNA and protein expression were down-regulated. Conclusion The low-expression of miR-218 is correlated with the poor clinicopathological features in human cervical cancer. MiR-218 overexpression reduces cancer cell proliferation and induces apoptosis and inhibits cell migration, suggesting that miR-218 may play a key role in the progression of human cervical cancer.

 

Keywords: MicroRNA-218, Cervical cancer, Proliferation, Apoptosis, Migration 

 

Full Text:

PDF


References


HISAMATUST, MABUCHI S. YOSHINO K, et al. Prediction of progression-free survival and response to paclitaxel plus carboplatin in patients with recurrent or advanced cervical cancer. Int J Gynecol Cancer,2012,22(4 ); 623-629.

KARA M, YUMRUTAS O, ATI LG AN R. et al. Expression changes of antioxidant. apoptotic, anti-apoptotic genes and miR-15b-34a-21-98 in over tissue by using erythromycin, quinacrine and tetracycline in non-surgical sterilization. Mol Biol Rep,2014,41 (12);8093-8098.

GAO Y. LI P. LIU Z. et al. Expression levels of vascular endothelial cell growth factor and microRNA-210 are increased in medulloblastoma and metastatic medulloblastoma. Exp Ther Med,2015.10 (6) ;2138-2144.

CHANG CC, YANG YJ, LI YJ, et al. MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma. Oral Oncol,2013,49(9) ;923-931.

CARTHEW RW, SONTHEIMER EJ. Origins and Mechanisms of miRNAs and siRNAs. Cell, 2009, 136(4); 642-55.

LEBANONY D. BENJAMIN H, GIL AD S, et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol,2009,27( 12):2030-2037.

FERRACIN M, VERONESE A, NEGRINI M. Micromarkers; miRNAs in cancer diagnosis andprognosis. Expert Rev Mol Diagn,2010,10(3) :297-308.

DENG M, TANG H, ZHOU Y,et al. miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma. J Cell Sci. 2011 , 124 ( 17); 2997- 3005.

HE X.DONG Y.WU C, et al. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulation BMI1 polycomb ring finger oncogene. Mol Med,2013,8( 18); 1491-1498.

YAMASAKI T,SEKI N, YOSHINO H,et al. MicroRNA- 218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway. J Urol.2013Л90(3): 1059-1068.

GADDUCCI A, TETI G, BAR90TTI C, et al. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage I 1>2 - II b cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy. Anticancer Res,2010,30( 1) :201-208.

TANG BB, LIU SY, ZHAN YU, et al. MicroRNA-218 expression and its association with the clinicopathological characteristics of patients with cervical cancer. Exp Ther Med,2015,10(1);269-274.

ANTIGNANI A, YOULE RJ. How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane. Curr Opin Cell Biol,2006,18(6) ;685-689.

LUANPITPONG S, CHANVORACHOTE P. STEHLIK C,et al. Regulation of apoptosis by Bcl-2 cysteine oxidation in human lung epithelial cells. Mol Biol Cell,2013,24 (6); 858- 869.

TSAIJH. YANG J. Epithelial-mesenchymal plasticity in rsrrinnma тртя<1яч1ч Гтрпрч DPV . ‘^01 Я . “)7( 90) . 1

WANG Z, LI Y, KONG D, et al. Acquisition of epithelial- mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res.2009,69(6):2400-2407.

JULIEN S, PUIG I, CARETTI E. et al. Activation of NF- kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene, 2007, 26( 53): 7445-7456.

LIU L, SALNIKOV AV, BAUER N, et al. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-kB downregulation. Int J Cancer,2014,134(10):2489-2503.


Refbacks

  • There are currently no refbacks.